This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Gerben Bouma: Innovator in Medical Therapy
Introduction
Gerben Bouma, an accomplished inventor based in Stevenage, GB, is recognized for his contributions to the field of medical therapy. With a focus on interleukin 7 (IL-7) binding proteins, Bouma has made significant strides in the development of pharmaceutical compositions aimed at treating various diseases and conditions.
Latest Patents
Bouma holds two important patents, both centered around IL-7 binding proteins. His latest patents detail the composition and application of these proteins in pharmaceutical therapies. These innovations provide essential insights into their use in treating or preventing diseases, showcasing Bouma's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Gerben Bouma is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he utilizes his expertise to foster innovation in pharmaceutical research. His work not only reflects his dedication to the field but also highlights the importance of intellectual property in supporting medical advancements.
Collaborations
Throughout his career, Bouma has collaborated with other talented professionals, including Edward Thomas Coulstock and David Dixon. These partnerships reflect the collective effort often required in the innovation process, emphasizing the role of teamwork in achieving significant breakthroughs in medical therapies.
Conclusion
In summary, Gerben Bouma is a noteworthy inventor whose work on IL-7 binding proteins paves the way for new therapeutic possibilities. His contributions to GlaxoSmithKline and the broader medical community underscore the value of innovation in enhancing healthcare solutions. As advancements continue, Bouma's inventions may play a crucial role in the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile